CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 99 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,702 | -25.0% | 44,730 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $76,936 | +113041.2% | 44,730 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $68 | -73.9% | 44,730 | -72.6% | 0.00% | -80.0% |
| Q4 2022 | $261 | -99.9% | 162,997 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $236,000 | -20.8% | 162,997 | 0.0% | 0.01% | -37.5% |
| Q2 2022 | $298,000 | -31.5% | 162,997 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $435,000 | +27.9% | 162,997 | +214.2% | 0.01% | 0.0% |
| Q4 2020 | $340,000 | -48.3% | 51,873 | -47.6% | 0.01% | -65.5% |
| Q3 2020 | $658,000 | +221.0% | 98,941 | +302.7% | 0.03% | +190.0% |
| Q2 2020 | $205,000 | -38.3% | 24,571 | -43.2% | 0.01% | -66.7% |
| Q1 2020 | $332,000 | -49.3% | 43,291 | -45.0% | 0.03% | +3.4% |
| Q4 2019 | $655,000 | – | 78,779 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |